Clinical Trial Update: Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of intravenous citrulline to prevent bronchopulmonary dysplasia in preterm infants has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Citrulline (intravenous) (Citrulline)

Snippet

Sponsor: Vanderbilt University | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: WITHDRAWN